[go: up one dir, main page]

WO2010107287A3 - Composition for trichogenousness using fetal mesenchymal stem cells from amniotic fluid - Google Patents

Composition for trichogenousness using fetal mesenchymal stem cells from amniotic fluid Download PDF

Info

Publication number
WO2010107287A3
WO2010107287A3 PCT/KR2010/001730 KR2010001730W WO2010107287A3 WO 2010107287 A3 WO2010107287 A3 WO 2010107287A3 KR 2010001730 W KR2010001730 W KR 2010001730W WO 2010107287 A3 WO2010107287 A3 WO 2010107287A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
mesenchymal stem
amniotic fluid
composition
trichogenousness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/001730
Other languages
French (fr)
Korean (ko)
Other versions
WO2010107287A2 (en
Inventor
유승권
윤병선
정혜연
전은경
문재희
김종건
이중한
박을순
맹이삭
김준성
이장호
이황희
이종원
조경식
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemmedience Co Ltd
Original Assignee
Stemmedience Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemmedience Co Ltd filed Critical Stemmedience Co Ltd
Publication of WO2010107287A2 publication Critical patent/WO2010107287A2/en
Publication of WO2010107287A3 publication Critical patent/WO2010107287A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a medium for fetal mesenchymal stem cells from amniotic fluid. More specifically, the present invention relates to a composition for trichogenousness or preventing depilation, which comprises the medium for fetal mesenchymal stem cells from amniotic fluid as an active ingredient. In addition, the present invention relates to a preparation method of the composition, which comprises: incubating fetal mesenchymal stem cells from amniotic fluid; and collecting the medium.
PCT/KR2010/001730 2009-03-20 2010-03-19 Composition for trichogenousness using fetal mesenchymal stem cells from amniotic fluid Ceased WO2010107287A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090024056A KR101218101B1 (en) 2009-03-20 2009-03-20 Compositions for Promoting Hair Growth Using Fetus-derived Mesenchymal Stem Cells from Amniotic Fluids
KR10-2009-0024056 2009-03-20

Publications (2)

Publication Number Publication Date
WO2010107287A2 WO2010107287A2 (en) 2010-09-23
WO2010107287A3 true WO2010107287A3 (en) 2011-01-20

Family

ID=42740152

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/001730 Ceased WO2010107287A2 (en) 2009-03-20 2010-03-19 Composition for trichogenousness using fetal mesenchymal stem cells from amniotic fluid

Country Status (2)

Country Link
KR (1) KR101218101B1 (en)
WO (1) WO2010107287A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6002352B2 (en) 2013-04-19 2016-10-05 コリア ユニバーシティ リサーチ アンド ビジネス ファウンデーションＫｏｒｅａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｂｕｓｉｎｅｓｓ Ｆｏｕｎｄａｔｉｏｎ Composition for promoting hair growth or preventing hair loss containing neural stem cell extract and method for producing the same
WO2016006788A1 (en) 2014-07-07 2016-01-14 메디포스트(주) Hair growth-promoting function of small-sized stem cells and use thereof
WO2016085250A1 (en) * 2014-11-28 2016-06-02 안동현 Hair growth-promoting composition
KR101779932B1 (en) 2015-09-15 2017-09-21 주식회사 스템랩 Method for producing of composition for promoting hair growth from human amniotic fluid-derived mesenchymal stem cells with nanog
KR102037038B1 (en) * 2017-01-11 2019-10-28 주식회사 스템랩 Method for producing exosome composition for promoting hair growth from human amniotic fluid-derived mesenchymal stem cells with nanog
KR102083081B1 (en) * 2018-05-30 2020-02-28 연세대학교 산학협력단 Composition for enhancing the action for hair growth of adipose stem comprising udenafil as an active ingredient
US20220133807A1 (en) * 2019-08-09 2022-05-05 Axolotl Biologix, Inc. Compositions derived from human amnion cells & related methods
KR102739923B1 (en) * 2024-07-03 2024-12-10 유한회사 스템메디케어 Use of pharmaceutical composition of immune-tolerized extracellular vesicles from fetal stem cells for hair loss treatment and manufacturing method thereof, and use of cosmetics composition for hair regeneration and hair loss alleviation containing immune-tolerized extracellular vesicles from fetal stem cells for hair loss treatment

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050205498A1 (en) * 2003-03-28 2005-09-22 Sowemimo-Coker Samuel O Preparation of a cell concentrate from a physiological solution
US20060088505A1 (en) * 2002-06-05 2006-04-27 Rolf Hoffmann Hair follicle mesenchymal stem cells and use thereof
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
KR20080063406A (en) * 2005-10-13 2008-07-03 안트로제네시스 코포레이션 Immune Regulation Using Placental Stem Cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789534B1 (en) * 2004-08-16 2014-08-06 CellResearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
KR100796817B1 (en) * 2005-03-23 2008-01-22 정용지 Growth Factors for the Treatment of Hair and Skin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060088505A1 (en) * 2002-06-05 2006-04-27 Rolf Hoffmann Hair follicle mesenchymal stem cells and use thereof
US20050205498A1 (en) * 2003-03-28 2005-09-22 Sowemimo-Coker Samuel O Preparation of a cell concentrate from a physiological solution
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
KR20080063406A (en) * 2005-10-13 2008-07-03 안트로제네시스 코포레이션 Immune Regulation Using Placental Stem Cells

Also Published As

Publication number Publication date
KR20100105167A (en) 2010-09-29
KR101218101B1 (en) 2013-01-03
WO2010107287A2 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
WO2010107286A3 (en) Composition for improving skin conditions using fetal mesenchymal stem cells from amniotic fluid
WO2010107287A3 (en) Composition for trichogenousness using fetal mesenchymal stem cells from amniotic fluid
WO2010021714A3 (en) Improved cell composition and methods of making the same
EP2727998A3 (en) Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
WO2008085221A3 (en) Therapeutic use of cd31 expressing cells
WO2012018881A3 (en) Methods and compositions for the regulation of rna
WO2010120757A3 (en) Regeneration of tissue without cell transplantation
WO2014053418A3 (en) Method for obtaining mesenchymal stem cells and use thereof
WO2009135905A3 (en) Mesenchymal stem cells and bone-forming cells
WO2011127409A3 (en) Methods and compositions related to fatty alcohol biosynthetic enzymes
WO2011031287A3 (en) Compositions and methods for the control of nematodes and soil borne diseases
JO2761B1 (en) 1Phenyl-2-Pyridinyl Alkyl Alcohol Derivatives As Phosphodiesterase Inhibitors
WO2009078965A8 (en) An improved process to prepare treprostinil, the active ingredient in remodulin®
WO2010039802A3 (en) Methods and compositions for isolating nucleic acid
WO2011109279A9 (en) Methods for purifying cells derived from pluripotent stem cells
WO2011066291A3 (en) Lyophilization methods, compositions, and kits
WO2013096838A3 (en) Systems and methods for isolating nucleic acids
WO2007074454A3 (en) Stable enzymatic preparations and methods of use thereof
WO2009092005A3 (en) Methods of generating cardiomyocytes and cardiac progenitors and compositions
WO2012096461A3 (en) Composition for suspension culturing of stem cells
WO2009112590A3 (en) Substances raising the activation threshold of immune cell
WO2011005289A3 (en) Methods and kits for measuring enzyme activity
WO2009036204A3 (en) Phase ii detoxification and antioxidant activity
WO2012078004A3 (en) Composition comprising fermented tea extracts for reducing lipid level

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10753737

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10753737

Country of ref document: EP

Kind code of ref document: A2